Johnson & Johnson subsidiary Cordis has filed suit against Boston Scientific of Natick, MA, alleging that its stents, including the Express2 device, infringe a patent owned by Cordis of New Brunswick, NJ. The suit seeks a declaration of validity and infringement of the patent, and injunctive and monetary relief.
In May 2002, the U.S. District Court for the District of Delaware set aside a jury verdict finding infringement of the same patent against Boston Scientific’s NIR stent.
By AuntMinnie.com staff writersJanuary 15, 2003
Related Reading
Boston Scientific, TriVascular form alliance, January 14, 2003
Boston Scientific biliary stent approved, October 30, 2002
Cook wins German patent fight vs. Boston Scientific, June 6, 2002
Boston Scientific debuts IVUS product, August 28, 2001
Guidant gets clearance for biliary stent , June 20, 2001
Copyright © 2003 AuntMinnie.com
